/
AZTA
$25.51+$0.01 (+0.04%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.2B
46M shares
52-week range
$15.93 – $41.73
37% from low
Sector
SPECIAL INDUSTRY MACHINERY, NEC
Exchange
NASDAQ
CS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-87.59
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $631.6M | $780.8M | $388.5M | $513.7M | $555.5M | $665.1M | $573.4M | $593.8M |
| Cost of revenue | $404.8M | $488.8M | $243.7M | $299.2M | $324.9M | $431.8M | $318.8M | $323.5M |
| Gross profit | $226.7M | $292.0M | $144.9M | $214.5M | $230.6M | $233.3M | $254.6M | $270.3M |
| Gross margin | 35.9% | 37.4% | 37.3% | 41.8% | 41.5% | 35.1% | 44.4% | 45.5% |
| R&D | $46.9M | $56.4M | $16.1M | $22.4M | $27.5M | $34.0M | $31.5M | $30.4M |
| Operating income | $34.4M | $55.1M | −$27.5M | $3.6M | −$24.0M | −$82.2M | −$30.0M | −$11.3M |
| EBITDA | $66.7M | $86.1M | $28.1M | $9.9M | $48.4M | $55.2M | $71.6M | $54.1M |
| Net income | $116.6M | $28.8M | $64.9M | $110.7M | −$429.0M | −$14.3M | −$164.9M | −$55.8M |
| Net margin | 18.5% | 3.7% | 16.7% | 21.6% | -77.2% | -2.1% | -28.8% | -9.4% |
| EPS (diluted) | 1.64 | 0.14 | 0.88 | -0.39 | -0.15 | -0.22 | -3.09 | -1.22 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $600M | $0.45 | $0.44–$0.45 | 3 |
| 2027 | $630M | $0.61 | $0.60–$0.62 | 2 |
| 2028 | $675M | $0.85 | $0.80–$0.89 | 2 |
| 2029 | $684M | $1.30 | $1.27–$1.31 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$12.49
Price
$25.51
Implied downside
-51%
Peer comparison
Azenta, Inc.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
www.azenta.com- Employees
- 2,900
- IPO / List date
- Feb 1, 1995
- HQ
- BURLINGTON, MA
Held by traders on TradeandTell
No one on the platform currently holds AZTA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 26,833 | $567.0K |
| Renaissance Technologiesas of 2025-03-31 | 16,344 | $566.2K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AZTA yet.
